Wutah pendapatan taunan sajrone rolas wulan kepungkur: Silo Pharma Inc. (SILO)

Logo grafis Silo Pharma Inc. (SILO)

Silo Pharma, Inc. (SILO) is focusing its development vector on creating psilocybin transdermal patches to combat neuropsychiatric pathologies. The company focuses on restoring cognitive functions in Alzheimer's disease using low doses of substances. Revenue is based on nasal delivery systems for the therapy of PTSD and dementia. The year-over-year product sales volume dynamics for the TTM demonstrate the asset's market position, where the current status is -49.90.

Wutah dodolan YoY sajrone rolas wulan kepungkur: Silo Pharma Inc. (SILO) kanggo 11.02.2024 - 18.11.2026

Silo Pharma - rincian analitis lan metrik utama (SILO)

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:Silo Pharma, SILO
Produk asil prodhuksi silopharma.com

The selection of high-quality issuers is based on an analysis of cash flow dynamics and business scaling rates via key multiples. This relative change in rolling year revenue compared to the same period last year captures the sales growth rate over the last twelve months, which is critical for Silo Pharma, Inc. (SILO) as it transitions from R&D to drug commercialization under strict FDA regulation and intellectual property protection.